Search research articles
Contact Us
Filters
Showing results (1-10 of 152) with videos related to
Page
of 16
Sort By:
La Revue De Medecine Interne
|
August 2, 2024
[Well-being, burn-out, resilience: words and ills of French Internal Medicine]
Yvan Jamilloux
Medecine Sciences : M/S
|
November 28, 2013
[The inflammasomes: platforms of innate immunity]
Yvan Jamilloux, Thomas Henry
Methods in Molecular Biology (Clifton, N.J.)
|
May 26, 2016
Cell-Free Assay for Inflammasome Activation
Yvan Jamilloux, Fabio Martinon
Joint Bone Spine
|
June 5, 2013
Online home self-assessment: a tool for improving future treatment trials… and daily practice: comments on the editorial by Berthelot JM, et al. "Online home self-assessment: a tool for improving future treatment trials?", Joint Bone Spine 2013;80:5-7
Yvan Jamilloux, Matthieu Sarabi
Rheumatology (Oxford, England)
|
December 7, 2019
Comment on: Improvement of MEFV gene variants classification to aid treatment decision making in familial Mediterranean fever
Yvan Jamilloux, Flora Magnotti
Annals of the Rheumatic Diseases
|
March 2, 2026
Correspondence on 'EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update' by Ozen et al
Yvan Jamilloux, Isabelle Kone-Paut
Ophthalmology
|
July 24, 2018
Re: Dick et al.: Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative (Ophthalmology. 2018;125:757-773)
Yvan Jamilloux, David Saadoun, Pascal Sève
Best Practice & Research. Clinical Rheumatology
|
August 31, 2023
VEXAS syndrome, a new kid on the block of auto-inflammatory diseases: A hematologist's point of view
Maël Heiblig, Bhavisha Patel, Yvan Jamilloux
Current Opinion in Hematology
|
February 2, 2023
VEXAS: where do we stand 2 years later?
Pierre Sujobert, Maël Heiblig, Yvan Jamilloux
British Journal of Haematology
|
May 24, 2019
Sodium valproate and dysmegakaryocytopoiesis
Cécile Dumas, Yvan Jamilloux, Anne-Lise Bienvenu
Page
of 16
Search research articles
Search
Showing results (1-10 of 152) with videos related to
Sort By:
Page
of 16
La Revue De Medecine Interne
|
August 2, 2024
[Well-being, burn-out, resilience: words and ills of French Internal Medicine]
Yvan Jamilloux
Medecine Sciences : M/S
|
November 28, 2013
[The inflammasomes: platforms of innate immunity]
Yvan Jamilloux, Thomas Henry
Methods in Molecular Biology (Clifton, N.J.)
|
May 26, 2016
Cell-Free Assay for Inflammasome Activation
Yvan Jamilloux, Fabio Martinon
Joint Bone Spine
|
June 5, 2013
Online home self-assessment: a tool for improving future treatment trials… and daily practice: comments on the editorial by Berthelot JM, et al. "Online home self-assessment: a tool for improving future treatment trials?", Joint Bone Spine 2013;80:5-7
Yvan Jamilloux, Matthieu Sarabi
Rheumatology (Oxford, England)
|
December 7, 2019
Comment on: Improvement of MEFV gene variants classification to aid treatment decision making in familial Mediterranean fever
Yvan Jamilloux, Flora Magnotti
Annals of the Rheumatic Diseases
|
March 2, 2026
Correspondence on 'EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update' by Ozen et al
Yvan Jamilloux, Isabelle Kone-Paut
Ophthalmology
|
July 24, 2018
Re: Dick et al.: Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative (Ophthalmology. 2018;125:757-773)
Yvan Jamilloux, David Saadoun, Pascal Sève
Best Practice & Research. Clinical Rheumatology
|
August 31, 2023
VEXAS syndrome, a new kid on the block of auto-inflammatory diseases: A hematologist's point of view
Maël Heiblig, Bhavisha Patel, Yvan Jamilloux
Current Opinion in Hematology
|
February 2, 2023
VEXAS: where do we stand 2 years later?
Pierre Sujobert, Maël Heiblig, Yvan Jamilloux
British Journal of Haematology
|
May 24, 2019
Sodium valproate and dysmegakaryocytopoiesis
Cécile Dumas, Yvan Jamilloux, Anne-Lise Bienvenu
Page
of 16